Ryman Healthcare

Aging Demographics And Urban Demand Will Transform Retirement Villages

AnalystHighTarget

Not Invested

Community Contributor

Published

20 Aug 25

AnalystHighTarget's Fair Value

NZ$3.50

19.7% undervalued

11 Sep

NZ$2.81

-42.1%

8.1%

-42.1%

8.1%

You can edit this narrative until Aug 20 9:29 PM. Then, changes will post as Updates.

Author's Valuation

NZ$3.519.7% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

NZ$3.5

19.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

7.10%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.97%

Calculation

NZ$504.19m

Earnings '28

10.56x

PE Ratio '28

NZ$5.32b

Market Cap '28

NZ$5.32b

Market Cap '28

1.24b

No. shares '28

NZ$4.28

Share Price '28

NZ$4.28 Share Price '28

Discounted to 2025 @ 6.99% p.a.

NZ$3.50

Fair Value '25